Sign In | Sign Up | Help | Invite    
Advanced Search Ask A Question Community Recent Changes
My:             Contributions   
Contributors
{for ul in pageInfo.page}
${ul.nickName}
{var al = toBreakWord(ul.adUrl,18)} {if ul.adSentence !=''}${ul.adSentence}
{/if} {if ul.adUrl !=''}${al}
{/if}
 
{/for}
Earn Free Advertising   +   Earn Money By Writing What You Know at WISTEME.COM
Question Discussion History

Edit
    Question ID:   4246         Current Version: 1
Question: How is HIV/AIDS diagnosed, are there any guidance for its treatment and prevention?
Category: Diseases & Conditions > Infectious Disease
Keywords: treatment, prevention, infection, disease, diagnosis, human immunodeficiency virus, AIDS, HIV
Type: other
Rating:(0 ratings)    Views: 320    Discussions: 0   In Watch Lists: 1  

 
    Answer:

Diagnosis

Because early HIV infection often causes no symptoms, a healthcare provider usually can diagnose it by testing blood for the presence of antibodies (disease-fighting proteins) to HIV. HIV antibodies generally do not reach noticeable levels in the blood for 1 to 3 months after infection. It may take the antibodies as long as 6 months to be produced in quantities large enough to show up in standard blood tests. Hence, to determine whether a person has been recently infected (acute infection), a healthcare provider can screen blood for the presence of HIV genetic material. Direct screening of HIV is extremely critical to prevent transmission of HIV from recently infected individuals.

Anyone who has been exposed to the virus should get an HIV test as soon as the immune system is likely to develop antibodies to the virus-within 6 weeks to 12 months after possible exposure to the virus. By getting tested early, a healthcare provider can give advice to an infected person about when to start treatment to help the immune system combat HIV and help prevent the emergence of certain opportunistic infections (see section on treatment). Early testing also alerts an infected person to avoid high-risk behaviors that could spread the virus to others.

Most healthcare providers can do HIV testing and will usually offer counseling at the same time. Of course, testing can be done anonymously at many sites if a person is concerned about confidentiality.

Healthcare providers diagnose HIV infection by using two different types of antibody tests: ELISA (enzyme-linked immunosorbent assay) and Western blot. If a person is highly likely to be infected with HIV but has tested negative for both tests, a healthcare provider may request additional tests. A person also may be told to repeat antibody testing at a later date, when antibodies to HIV are more likely to have developed.

Diagnosis in Babies

Babies born to mothers infected with HIV may or may not be infected with the virus, but all carry their mothers' antibodies to HIV for several months. If these babies lack symptoms, healthcare providers cannot make a definitive diagnosis of HIV infection using standard antibody tests. Instead, they are using new technologies to detect HIV and more accurately determine HIV infection in infants between ages 3 months and 15 months. Researchers are evaluating a number of blood tests to determine which ones are best for diagnosing HIV infection in babies younger than 3 months.

Treatment

When AIDS first surfaced in the United States, there were no drugs to combat the underlying immune deficiency, and few treatments existed for the opportunistic diseases that resulted. Researchers, however, have developed drugs to fight both HIV infection and its associated infections and cancers.

HIV infection

The Food and Drug Administration (FDA) has approved a number of drugs for treating HIV infection.

RT Inhibitors

The first group of drugs, called reverse transcriptase (RT) inhibitors, interrupts an early stage of the virus, making copies of itself. Nucleoside/nucleotide RT inhibitors are faulty DNA building blocks. When these faulty pieces are incorporated into the HIV DNA (during the process when the HIV RNA is converted to HIV DNA), the DNA chain cannot be completed, thereby blocking HIV from replicating in a cell. Non-nucleoside RT inhibitors bind to reverse transcriptase, interfering with its ability to convert the HIV RNA into HIV DNA. This class of drugs may slow the spread of HIV in the body and delay the start of opportunistic infections.

Protease Inhibitors

FDA has approved a second class of drugs for treating HIV infection. These drugs, called protease inhibitors, interrupt the virus from making copies of itself at a later step in its life cycle.

Fusion Inhibitors

FDA also has introduced a third new class of drugs, known at fusion inhibitors, to treat HIV infection. Fuzeon (enfuvirtide or T-20), the first approved fusion inhibitor, works by interfering with the ability of HIV-1 to enter into cells by blocking the merging of the virus with the cell membranes. This inhibition blocks HIV's ability to enter and infect the human immune cells. Fuzeon is designed for use in combination with other anti-HIV treatments. It reduces the level of HIV infection in the blood and may be effective against HIV that has become resistant to current antiviral treatment schedules.

HAART

Because HIV can become resistant to any of these drugs, healthcare providers must use a combination treatment to effectively suppress the virus. When multiple drugs (three or more) are used in combination, it is referred to as highly active antiretroviral therapy, or HAART, and can be used by people who are newly infected with HIV as well as people with AIDS. Recently, FDA approved the first one-a-day, three-drug combination pill called Atripla.

Researchers have credited HAART as being a major factor in significantly reducing the number of deaths from AIDS in this country. While HAART is not a cure for AIDS, it has greatly improved the health of many people with AIDS, and it reduces the amount of virus circulating in the blood to nearly undetectable levels. Researchers, however, have shown that HIV remains present in hiding places, such as the lymph nodes, brain, testes, and retina of the eye, even in people who have been treated.

Side effects

Despite the beneficial effects of HAART, there are side effects associated with the use of antiviral drugs that can be severe. Some of the nucleoside RT inhibitors may cause a decrease of red or white blood cells, especially when taken in the later stages of the disease. Some may also cause inflammation of the pancreas and painful nerve damage. There have been reports of complications and other severe reactions, including death, to some of the antiretroviral nucleoside analogs when used alone or in combination. Therefore, health experts recommend that anyone on antiretroviral therapy be routinely seen and followed by their healthcare provider.

The most common side effects associated with protease inhibitors include nausea, diarrhea, and other gastrointestinal symptoms. In addition, protease inhibitors can interact with other drugs, resulting in serious side effects. Fuzeon may also cause severe allergic reactions such as pneumonia, difficult breathing, chills and fever, skin rash, blood in urine, vomiting, and low blood pressure. Local skin reactions are also possible since it is given as an injection underneath the skin. People taking HIV drugs should contact their healthcare providers immediately if they have any of these symptoms.

Opportunistic infections

A number of available drugs help treat opportunistic infections. These drugs include 

  • Foscarnet and ganciclovir to treat CMV (cytomegalovirus) eye infections
  • Fluconazole to treat yeast and other fungal infections
  • TMP/SMX (trimethoprim/sulfamethoxazole) or pentamidine to treat PCP (Pneumocystis carinii pneumonia)

Cancers

Healthcare providers use radiation, chemotherapy, or injections of alpha interferon-a genetically engineered protein that occurs naturally in the human body-to treat Kaposi's sarcoma or other cancers associated with HIV infection.

Prevention

Because there is no vaccine for HIV, the only way people can prevent infection with the virus is to avoid behaviors putting them at risk of infection, such as sharing needles and having unprotected sex.

Many people infected with HIV have no symptoms. Therefore, there is no way of knowing with certainty whether a sexual partner is infected unless he or she has repeatedly tested negative for the virus and has not engaged in any risky behavior.

Abstaining from having sex or using male latex condoms or female polyurethane condoms may offer partial protection, during oral, anal, or vaginal sex. Only water-based lubricants should be used with male latex condoms.

Although some laboratory evidence shows that spermicides can kill HIV, researchers have not found that these products can prevent a person from getting HIV.

Recently, NIAID-supported two studies that found adult male medical circumcision reduces a man's risk of acquiring HIV infection by approximately 50 percent. The studies, conducted in Uganda and Kenya, pertain only to heterosexual transmission. As with most prevention strategies, adult male medical circumcision is not completely effective at preventing HIV transmission. Circumcision will be most effective when it is part of a more complete prevention strategy, including the ABCs (Abstinence, Be Faithful, Use Condoms) of HIV prevention.

Read more questions from WISTEME through
     Add to MSN Add to My AOL
 Rate this Question
   Add to Groups   Add to Watch Lists   Share Question
                          
 
    More Readings :
[QID:4244]    What are the symptoms of HIV/AIDS?  
[QID:3553]    How is tuberculosis diagnosed, treated and prevented?  
[QID:4379]    What do I need to know about hookworm disease?  
[QID:4245]    What do I need to know about the tularemia?  
[QID:4375]    Why friend was told she can't get pregnant because she has pelvic inflammatory disease (PID). Is this true?  
[QID:4267]    What is the tickborne disease?  
[QID:4249]    What do I need to know about the whipworm disease?  
[QID:4319]    What do I need to know about stomach cancer?  
[QID:3520]    What do I need to know about cirrhosis of the liver?  
[QID:3521]    What do I need to know about gastroparesis?  
     Question ID:  ${question.id}         Current Version:  ${question.version}

{for qh in questionHistory} {if qh.status == 'r'} {else} {/if} {/for}
Version Contributor Date (ET) Voting
${qh.version} ${qh.nickName} ${qh.date} Rejected
${qh.version} ${qh.nickName} ${qh.date} {if qh.status != 'c'} {if qh.status == 'a'} Approved {else} {if qh.rstatus == 'c'} On-going {else} Pending {/if} {/if} {else}   {/if}
Start a New Topic
ID Topics Replies Latest Post (ET)
{if dlist!=null} {for d in dlist} {/for}
${parseInt(d_index)+1} ${d.sentence} ${d.replyNum} ${d.lastestDate}
{else}
No discussion topic.
{/if}
Label Name:
 
Group Name:
 
 
{else}
     You have no group.
{/if}
Advertisements
{if advertisements.length > 0} {else} {/if}
{for ad in advertisements}
${ad.adTitle}
${ad.adSentence}
${ad.adUrl}
{/for}

Home | About Us | Terms of Use | Privacy Policy | Browse Questions | RSS Feed

Copyright ©2010 WISTEME LLC. All Rights Reserved.